Previous Article | Next Article ![]()
Journal of Virology, November 2008, p. 11084-11095, Vol. 82, No. 22
0022-538X/08/$08.00+0 doi:10.1128/JVI.01377-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Rong-Xiang Fang,1 and
Hui-Shan Guo1*
State Key Laboratory of Plant Genomics and National Center for Plant Gene Research (Beijing), Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China,1 Graduate University of Chinese Academy of Sciences, Beijing 100049, China2
Received 1 July 2008/ Accepted 25 August 2008
|
|
|---|
|
|
|---|
10 nt from the 5' end of this guide small RNA, and the cleaved target mRNA is then degraded (24, 30, 44, 50). In addition to cleavage of target mRNA, a widespread translational inhabitation by plant miRNAs and siRNAs has recently been reported (7). To express specific miRNAs, short-hairpin RNAs based on miRNA precursor backbones (artificial miRNAs [amiRNAs]) are the most successful expression cassettes to induce highly specific gene silencing in Arabidopsis thaliana and in rice (1, 10, 19, 35, 37, 43, 52, 53). Potential application of amiRNAs as antiviral agents in plant biotechnology has also been reported recently (34, 38). Over the last decade, the homology-dependent RNA-mediated silencing has widely been used to engineer antiviral resistance in plants by the expression of viral sequences in the sense or antisense orientation or in the double-stranded forms (20, 47, 54). In these cases, cosuppression of both the virus-derived transgene RNA and the invading viral RNA would occur via RNA silencing, resulting in high resistance or delayed resistance (recovery) to virus challenge (18, 27). Compared to long RNA-mediated antiviral silencing, amiRNA has several advantages for generating viral immunity. First, a long viral cDNA fragment is not required. A short amiRNA sequence without extensive homology to any plant genes can be chosen to avoid off-target effects. Second, the amiRNA-mediated approach has no environmental biosafety problem when applied in agriculture. Concerns about transforming plants with viral sequences that might complement or recombine with nontarget viruses clearly do not apply to plants expressing amiRNAs (17).
Efficient amiRNA-mediated resistance to infection with a tymovirus, Turnip yellow mosaic virus, and a potyvirus, Turnip mosaic virus, has been observed in transgenic A. thaliana expressing amiRNAs targeting viral mRNA sequences that encode the silencing suppressors P69 of Turnip yellow mosaic virus and HC-Pro of Turnip mosaic virus (34). However, transgenic tobacco plants expressing an amiRNA targeting the sequence that encodes the silencing suppressor 2b of the Cucumber mosaic virus (CMV) showed various degrees of responses to CMV infection, including "resistant," "recovery," "delayed infection," and "susceptible" (39). The low resistance might be due to the multiple genomes of CMV, which contain three genomic and two subgenomic RNAs. The CMV genomic RNA1 and RNA3, as well as subgenomic RNA4, are not direct targets of amiR2b, and siRNAs derived from these nontarget RNAs rapidly accumulate in plant cells, which may lead to saturation of siRISC and impair amiR2b antiviral efficacy. It may also be possible that the amiR2b target site is not in the optimal siRISC-target recognizing region.
It is generally recognized that not all siRNA species against a given mRNA target are equally effective. The efficacy of RNA silencing depends not only on the nature of siRNAs but also on the local structures of the target mRNAs (31, 36, 42). Engineered Plum pox virus (PPV) chimeras bearing endogenous functional miRNA target sequences that impair viral infectivity have been reported (46). The deleterious effect on virus infectivity also depends on the site of insertion of the miRNA target sequence in the viral genome, indicating that some sites are more accessible than others to the miRNA-RISC-mediated cleavage. Moreover, Simon-Mateo and Garcia (46) have also studied the stability of the PPV chimeric genome and found selections of virulent mutants in the plants infected with the PPV chimeras. These mutants contain mutations within the miRNA target sequence that mainly affect nucleotide matching to the 5'-terminal region of the miRNA, indicating that virus can readily evolve to escape the amiRNA-mediated silencing mechanism under the negative pressure of miRNA activity (46).
Target site accessibility that can influence siRNA-programmed RISC catalysis has been analyzed by biochemical and bioinformatics approaches in animal cell lines (2, 8, 45). Computational modeling of the secondary structure of a target and assessment of the effect of secondary structure on target accessibility can be predicted via bioinformatics methods. However, the major drawback for diverse applications of siRNA-mediated target RNA cleavage in medicine and in agriculture is the lack of tools to accurately and reliably predict secondary structures within long RNAs that are adopted in their native conditions in vivo since an mRNA is unlikely to have a single stable structure.
CMV is one of the best-characterized tripartite positive-sense single-stranded RNA viruses (48), and it can be divided into three subgroups: IA, IB, and II (41). High nucleotide sequence similarity is present within the 3' untranslated region (3'UTR) of multiple RNA genomes of CMV, and the homology in the 3'UTR sequences is extensive among the three genomes and the two subgenomes. The similarities between the 3'UTR are even more apparent when secondary structures are considered since they can all be base paired to form a tRNA-like structure (TLS) (26, 40). It has been shown that the TLS segment contains the promoter for minus-strand synthesis of the viral RNA during replication, and the primary function of the TLS is to interact with the replicase (e.g., the 1a and 2a proteins encoded by RNA1 and -2, respectively) and other host factors (15). The importance of the 3'UTR in CMV replication and the high stability of nucleotide sequence and three-dimensional structures of TLS prompt us to explore antiviral activity using 3'UTR-based amiRNA-mediated RNA silencing.
In the present study, we used an experimental approach to analyze the effect of target site accessibility and to engineer effective anti-CMV silencing in plants by amiRNAs. We compared the natural cleavage hot spot sites within the 3'UTR of the CMV-infected wild-type Arabidopsis to those of the triple dcl2/3/4 Arabidopsis mutant. In the triple dcl mutant, three of the four DCL proteins, DCL2, DCL3, and DCL4, which show hierarchical antiviral activities in addition to their endogenous function in Arabidopsis, are mutated, and only DCL1 may be functional for processing hairpin RNAs in the miRNA pathway (6, 12, 16, 33, 51, 58). Moreover, with the plant transient-expression assay, potential DCL- and RISC-mediated cleavage sites in the viral RNA were evaluated under natural viral infection conditions. We found that transgenic plants expressing amiRNAs that target the putative DCL-mediated cleavage sites, such as those in the TLS region, showed no protection against CMV infection. However, both transgenic Arabidopsis and tobacco expressing amiRNAs that target the putative RISC accessible sites conferred a high resistance to CMV challenge from both subgroup strains. amiRNAs were also expressed in transgenic plants carrying a polymeric amiRNA precursor, which ligated three amiRNA monomers into a single transcription unit; these plants also conferred high resistance to CMV infection.
|
|
|---|
amiRNA precursor PCR DNA fragment was ligated into pGEM-T vector and cloned into binary vector pCAMBIA-1300221 to generate pCAMBIA-pre-amiRNA, in which pre-amiRNAs are placed downstream of the 35S promoter.
To obtain amiR-SD-2/3/5 precursor, an XbaI-SpeI fragment of pGEM-T-pre-amiR-SD-3 was inserted into SpeI-digested 35S-pre-amiR-SD-2, giving 35S-pre-amiR-SD-2/3. An XbaI-SpeI fragment of pGEM-T-pre-amiR-SD-5 was inserted into SpeI-digested 35S-pre-amiR-SD-2/3 and generated 35S-pre-amiR-SD-2/3/5.
Construction of CMV subgenomic RNAs and β-glucuronidase (GUS)-sensor. Plasmid pQCD1 containing the cDNA clone of Q-CMV RNA1 (13) was digested with XhoI-BamHI, a 962-nt fragment corresponding to the 3' termini of Q-CMV RNA1 was cloned into pCAMBIA-1300221 to generate 35S-R1*. Q-CMV subgenomic RNA4A and RNA4 sequences were amplified by PCR using pQCD2 and pQCD3 (which contain the cDNA clones of Q-CMV genomic RNA2 and RNA3, respectively) (13) as templates, respectively. The forward primers QR4-5 (5'-TCTAGAAGCGTTTAGTTGTTCACCTG-3') and QR4A-5 (5'-TCTAGAGTTTTGTATATCTGAGTTCC-3') contain the XbaI site (indicated in italics). The reverse primers QR4-3 (5'-GAGCTCTGGTCTCCTTATGGAGAAC-3') and QR4A-3 (5'-GAGCTCTGGTCTCCTTATGGAGAACC-3') contain the SacI site (indicated in italics). The XbaI-SacI fragments were cloned into XbaI/SacI-digested pCAMBIA-1300221, giving 35S-R4 and 35S-R4A.
A GUS-sensor construct, in which the GUS was fused to the amiR-Q-1 target sequence, was created by PCR amplification. pCAMBIA-1300221 was used as a template, and a pair of primers was designed to amplify a 426-bp fragment of the 3' terminus of the GUS-amiR-Q-1 target sequence (GUS-sensor fragment). The forward primer GUS-sensor-5 (5'-TGTACAGCGAAGAGGCAGTC-3') contains the BsrGI site (indicated in italics) and the reverse primer GUS-sensor-3 (5'-TGTACAGTGCACGAGCTTCTCACGAAGTTGAGTGCAGCCCGGCTAAC-3') contains the BsrGI site (indicated in italics) and introduced a 21-nt sequence (underlined) complementary to 2105 to 2125 nt of the Q-CMV RNA3, a region corresponding to cleavage hot spot sites obtained from the 35-R4 infiltration assay. The generated GUS-sensor fragment was digested with BsrGI and replaced the corresponding GUS 3'-terminus sequence in pCAMBIA-1300221, giving 35S-GUS-sensor.
Plant transformation and virus inoculation. Arabidopsis transformation was carried out by the floral dip method (11) and tobacco transformation by coculture with Agrobacterium tumefaciens. The selective medium contained MS medium plus hygromycin 20 mg/liter. Leaves of 4-week-old Arabidopsis and tobacco plants were infected with a fresh sap prepared from CMV-infected tobacco leaves (1 g of ground leaf material diluted into 5 ml of phosphate buffer). All plants examined in the present study were continuously monitored over the whole experiment (about 2 months).
5'RLM-RACE assay. The 5'RACE (rapid amplification of cDNA ends) assay was performed by using the First Choice RLM-RACE kit (Ambion). Portions (2 µg) of total RNAs were used for direct ligation to the 5'RACE RNA adapter, and subsequent steps were done according to the manufacturer's directions. PCR fragments obtained from 5'RACE were cloned into the pGEM-T vector (Promega), and individual clones were selected for DNA sequencing.
Northern blot hybridizations.
Total RNA was isolated from plant tissues using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. For high-molecular-weight RNA blots, 10 µg of total RNA was loaded. [
-32P]dCTP-labeled cDNA probes specific for the respective RNA were used. For low-molecular-weight RNA blots, 30 µg of total RNA was loaded. [
-32P]UTP-labeled transcript or [
-32P]ATP-labeled specific oligonucleotide probe sequences was used.
ELISA detection of virus accumulation. Enzyme-linked immunosorbent assay (ELISA) was carried out using a polyclonal antiserum to the Q-CMV or SD-CMV coat protein (CP). Polyclonal antiserum to SD-CMV CP was also used in the detection of Fny-CMV CP because of the high identity (98.2%) of amino acid sequences between the SD-CMV and Fny-CMV CP. Readings were taken 1 h after substrate hydrolysis.
|
|
|---|
100 bp (Fig. 1), suggesting that the decrease in RNA4 might result from the cleavage of RNA4 at certain regions or points that excelled the 3'UTR-derived siRNA-mediated random degradation of RNA4. Coinfiltration experiments with combinations of the target RNA and small RNA indicated that cleavage of RNA4 was likely to have been mediated by DCLs (see second section of Results and Fig. 3). Similar site-specific cleavage was observed from the transient expression of CMV subgenomic RNA4A (encoding the 2b protein) and the 3' terminus of genomic RNA1 (encoding part of the 1a protein), both containing the full 3'UTR sequence (named as 35S-R4A and 35S-R1*, respectively; Fig. 1).
![]() View larger version (61K): [in a new window] |
FIG. 1. Site-specific cleavage of transient expression of Q-CMV RNAs. Northern blot analysis of transient expression of Q-CMV RNAs (RNA4, RNA1*, and RNA4A) in N. benthamiana infiltrated with 35S-R4, 35S-R1*, or 35S-R4A. 32P-labeled DNA probes specific for the full-length 3'UTR of each corresponding Q-CMV genome RNAs were used. The specific cleavage product is indicated. 32P-labeled transcript probes specific for each corresponding 3'UTR were used for detection of the 3'UTR-derived siRNAs. RNA loading was monitored by methylene blue staining of the rRNA.
|
![]() View larger version (58K): [in a new window] |
FIG. 3. Analysis of amiRNA-mediated cleavage of the target RNAs by a transient assay. Northern blot analysis of transient expression of RNAs in N. benthamiana coinfiltrated with 35S-R4 or GUS-sensor construct with one of the pre-amiRNAs as indicated on the top of panels. 32P-labeled DNA probes specific for the full-length 3'UTR of Q-CMV RNA4 or GUS mRNA were used, respectively. Specific cleavage products are indicated.
|
![]() View larger version (55K): [in a new window] |
FIG. 2. Mapping of the cleavage sites of the 3'UTR RNA and analysis of the 3'UTR-derived siRNAs. (A) Mapping of the cleavage site of the 3'UTR of CMV genomic RNA3 by 5'RACE. An alignment of each of the RNA3 3'UTRs of three CMV strains is shown. Identical nucleotides within the three strains and any two strains are highlighted in green and purple, respectively. The TLS region is indicated. Outer and inner primers specific for Q-CMV (red) and SD-CMV (black) for 5'RACE are labeled. Mapped cleavage sites are indicated with hollow red arrows (from transient expression of 35S-R4), solid red arrows (from Q-CMV-infected N. glutinosa), solid black arrows (from SD-CMV-infected wild-type Arabidopsis), and hollow black arrows (from SD-CMV-infected triple dcl2/3/4 mutant Arabidopsis). amiRNAs specifically targeting Q-CMV and SD-CMV 3'UTR sequences are marked with red and black lines, respectively, above the aligned sequences. Putative target accessibility is labeled with RISC-accessible or non-RISC-accessible above the given amiRNAs. (B) Similar developmental defects caused by SD-CMV infection in Arabidopsis wild-type Col-0 and dcl2/3/4 mutant and infection symptoms in influorescences (inset) are shown. Photographs were taken at 20 days postinfection. (C) Northern blot analysis of the 3'UTR-derived siRNA accumulation in the SD-CMV-infected wild-type or triple dcl2/3/4 mutant A. thaliana. 32P-labeled specific oligonucleotide probe sequences (a mixture) complementary to the 3'UTR regions were used. The membrane was stripped and rehybridized with miR159 as a loading control.
|
Designing and transient expression of amiRNAs and amiRNA-mediated cleavage of target RNAs. The preferred putative siRISC cleavage site in the SD-CMV 3'UTR was between nt 148 and 149 (nt 148/149) (Fig. 2A) in the cleavage hot spot, where cleavage was detected one and four times in the wild type and dcl2/3/4 mutant, respectively. A U nucleotide at the position immediately after the cleavage site is also consistent with the endonuclease-preferred slicing position found in most miRNA-mediated cleavage of target mRNAs (22, 39). Sequence alignment showed that the amiRNA targeting area was highly conserved in the 3'UTR regions of all three SD-CMV genome RNAs (data not shown). Moreover, the sequence was also conserved in the three genome RNAs of Fny-CMV (a subgroup IA strain) and Q-CMV RNA3, but it differed by 5 nt in Q-CMV RNA1 and RNA2 (data not shown). This amiRNA is referred to as amiR-SD-3 (Fig. 2A).
The second amiRNA (amiR-SD-2) was designed to target the cleavage site at nt 163 and 164, which was detected twice in the dcl2/3/4 mutant (Fig. 2A). Sequence alignment showed that the amiR-SD-2 target sequence was highly conserved in the 3'UTR of all three genome RNAs in SD- and Fny-CMV but not in Q-CMV (Fig. 2A). Therefore, we designed amiR-Q-2 to specifically target the same area of the 3'UTR in Q-CMV (Fig. 2A).
amiR-SD-5 was designed to target the 3'UTR region that was conserved in the three CMV strains with the cleavage site (nt 84/85), detected once and twice in the wild type and dcl2/3/4 mutant, respectively (Fig. 2A).
For the control, we designed amiR-SD-4 to target an area (nt 115/116) that was not in the cleavage hot spot but was still quite conserved in the 3'UTR of different CMV strains (Fig. 2A), and amiR-Q-1 was designed to target the TLS region, which contains the cleavage sites (nt 241/242 and nt 242/243) that were detected three and six times with transient expression samples; this cleavage seemed to be mediated by DCLs but not by siRNA-RISC (see below). Since the target area sequence of amiR-Q-1 was not conserved among Q-, SD-, and Fny-CMV, we also designed an amiR-SD-1 that is adjacent to the target area of ami-Q-1 to target the area in the TLS region that is conserved in all three CMV strains (Fig. 2A).
Because Arabidopsis miRNA precursor MIR159a has been shown to be effective in expressing artificial miRNAs (34), we chose Arabidopsis pre-miR159a as a backbone for the construction and expression of amiRNAs. Using oligonucleotide-directed mutagenesis, we replaced the 21-nt sequence of miR159 with the synthetic sequences, each corresponding to an amiRNA named pre-amiR-SD-1, -2, etc. Transient expression of each amiRNA was confirmed by Northern blot analysis (data not shown). To create a high level of resistance to CMV, particularly to the severe field strains, we constructed a polymeric amiRNA precursor by ligating pre-amiR-SD-2, pre-amiR-SD-3, and pre-amiR-SD-5 and by expressing the polymer in a single transcription unit under the 35S promoter; this construct was named 35S-amiR-SD-2/3/5. Transient expression of each amiRNA was confirmed by Northern blot analysis (data not shown).
amiRNA-mediated cleavage of the target RNAs was confirmed by coinfiltrating N. benthamiana leaves with agrobacterial cells carrying plasmids containing the target constructs and the proper pre-amiRNAs (Fig. 3, left panel, and data not shown). Figure 3 shows amiR-Q-2-mediated cleavage of the target RNA4 transcript. An additional hybridization signal was specifically detected with the coinfiltration of 35S-R4 with amiR-Q-2, compared to the coinfiltration of 35S-R4 with amiR-Q-1, in which the hybridization signals were similar to those observed with 35S-R4 infiltration alone (Fig. 1) or with coinfiltration of pre-miR159a (Fig. 3, left panel). To examine whether the synthetic amiR-Q-1 was biologically functional, a GUS-sensor construct, in which the GUS was fused to the amiR-Q-1 target sequence, was coinfiltrated into N. benthamiana with amiR-Q-1 or amiR-Q-2. Northern blot analysis showed that amiR-Q-1 could mediate cleavage of the GUS-sensor RNA (Fig. 3, right panel), indicating that the synthetic amiR-Q-1 was biologically functional but simply not able to program RISC-mediated cleavage of RNA4. This result revealed that the amiR-Q-1 target site, which was located in the TLS region, was not accessible by siRNA-RISC. Without complementary sequences between the GUS-sensor and amiR-Q-2, amiR-Q-2 did not mediate cleavage of the GUS-sensor RNA. This result also indicated that there was no endogenous siRNA-mediated cleavage of GUS-sensor RNA at the amiR-Q-1 target site, suggesting that the cleavage product detected in the 35S-R4 infiltration assay (Fig. 1A) did not result from endogenous siRNA-mediated cleavage but that it probably derived from DCL-mediated cleavage at the TLS region.
Specificity of amiRNAs in transgenic plants. Constructs of 35S-amiR-SD-1, -2, -3, -4, -5, and -2/3/5 were transformed into both A. thaliana (Columbia) and Nicotiana tabacum (Xanthi-nc); 35S-amiR-Q-1 and -2 were transformed into tobacco only since Q-CMV does not cause clear disease symptoms in Arabidopsis. We verified the expression of each amiRNA in the transgenic lines (Fig. 4A, 6A, and data not shown).
![]() View larger version (43K): [in a new window] |
FIG. 4. Analysis of resistance to SD-CMV infection in the transgenic A. thaliana plants expressing amiRNAs. (A) Detection of amiRNA expression levels in three independent lines of transgenic T2 progeny plants carrying 35S-amiR-SD-1, -2, -3, -4, -5, and -2/3/5. The miR159 was used as a loading control. Line numbers are indicated on the top. (B) Transgenic T2 progeny plants were inoculated with SD-CMV and photographs were taken at 12 dpi, one representative line (indicated on top) of each genotype plants is shown. Bar, 3 cm. (C) ELISA detection of SD-CMV CP in upper noninoculated leaves of SD-CMV inoculation plants at 16 dpi. Bars represent the standard deviations (n = 12). (D) Time course of SD-CMV titer in upper leaves of various transgenic T3 homozygote lines (as labeled) and wild-type plants at 0, 4, 8, 12, and 16 dpi. Bars show the standard deviations (n = 12).
|
![]() View larger version (59K): [in a new window] |
FIG. 6. amiRNA transgenic tobacco plants showed different resistances to Q-, SD-, and Fny-CMV infection. (A) Detection of amiRNA expression levels in the transgenic T1 progeny of each genotype. (B, D, and F) Plants were infected with Q-CMV (B), SD-CMV (D), or Fny-CMV (F), respectively. Photographs of systemic noninoculated leaves of representative line of each genotype are shown (16 dpi). Bar, 2 cm. (C, E, and G) ELISA detection of Q-CMV (C), SD-CMV (E), or Fny-CMV (G) CP in upper noninoculated leaves of three CMV strains or mock inoculation of each genotype plants at 16 dpi. Bars represent the standard deviations (n = 6). (H, I, and J) Time course analysis of CMV titer by ELISAs. Transgenic tobacco plants carrying 35S-amiR-SD-1, -3, and -2/3/5 and 35S-amiR-Q-1 and -2 T1 progeny and wild-type plants were inoculated by Q-CMV (H), SD-CMV (I), or Fny-CMV (J). Samples were collected from systemic noninoculated leaves of one representative line (as in panels B, D, and F) of each genotype and from wild-type plants at 0, 4, 8, 12, and 16 dpi. Readings were taken 1 h after substrate hydrolysis. Bars show standard deviations (n = 5).
|
![]() View larger version (31K): [in a new window] |
FIG. 5. Transcript analysis of the predicted target gene (AT3G29250) of amiR-SD-3 in wild-type and amiR-SD-3 transgenic A. thaliana by semiquantitative reverse transcription-PCR. Endogenous actin transcript was used as a control. PCR amplification cycles are indicated. The AT3G29250 transcript/amiR-SD-3 pair containing three mismatches in base pairing is shown.
|
CMV resistance of transgenic Arabidopsis. SD-CMV causes severe disease symptoms in Arabidopsis ecotype Columbia, including stunting, reduced internodal distances, curly inflorescence, and snaky siliques (Fig. 2B) (14). Wild-type and three independent lines of each transgenic amiRNA Arabidopsis (T2 progeny, including homozygotes and hemizygotes) were challenged with sap extracted from SD-CMV-infected tobacco plants (Table 1, experiment 1). At 12 days postinoculation, typical disease symptoms were observed in 26 of 27 wild-type plants, in all plants from two amiR-SD-1 lines (lines 3 and 6) and in 22 of 24 plants of the amiR-SD-1 line 1 (Fig. 4B and Table 1). Most plants of the amiR-SD-4 lines (18, 16, and 20 out of 24 of lines 4, 7, and 8, respectively) were susceptible to SD-CMV infection. In contrast, all plants from the three amiR-SD-3 lines (lines 1, 2, and 7) did not show any apparent disease symptom (Fig. 4B and Table 1). Similar results were also obtained from all plants of the three polymer amiR-SD-2/3/5 lines (lines 2, 4 and 6), which showed 100% resistance to SD-CMV. amiR-SD-2 lines (lines 2, 3, and 4) and amiR-SD-5 lines (lines 4, 5, and 6) were clearly protected against SD-CMV infection with resistance levels ranging between 91.7 and 100% and between 83.8 and 100%, respectively (Fig. 4B and Table 1).
|
View this table: [in a new window] |
TABLE 1. Infectivity assay of amiRNA transgenic Arabidopsis challenged with SD-CMV
|
A second experiment was performed to monitor the development of disease symptoms and SD-CMV CP accumulation in the T3 progeny (homozygotes) plants of all genotypes. Most plants from the amiR-SD-1 lines were highly susceptible to SD-CMV infection just like the wild-type plants (Table 1). A low level of resistance was also found for the amiR-SD-4 plants (18.8 to 28.6%), similar to the results from the T2 plants. However, T3 progenies of all amiR-SD-2, -3, -5, and -2/3/5 lines were 100% resistant to SD-CMV. Figure 4D shows a course ELISA with the average readings from plants derived from one line of each genotype. Together, these results indicate that amiR-SD-2, -3, and -5, but not amiR-SD-4 and amiR-SD-1, can confer a high level of resistance to SD-CMV infection. Among the single constructs, amiR-SD-3, whose targeting area is in the cleavage hot spot mediated by siRNA-RISC (Fig. 2A), is likely to be the best amiRNA for conferring resistance to SD-CMV infection. Consistent with this result, the polymer amiR-SD-2/3/5 also conferred the highest resistance to infection (Table 1). Our results also showed that the resistance trait can be transmitted to the next generation.
CMV resistance of transgenic tobacco. N. tabacum is a native host of CMV. Typically, Q-CMV causes a chlorosis in the systemically infected leaves of the wild-type tobacco. SD-CMV and Fny-CMV-infected wild-type tobacco develops more pronounced disease symptoms, with striking chlorosis and curling in the systemically infected leaves (Fig. 6B, D, and F).
We first examined the Q-CMV resistance conferred by amiRNAs in the transgenic tobacco plants. Based on the resistance data from transgenic Arabidopsis plants, we chose amiR-SD-3, -2/3/5, and -1 transgenic tobacco lines, as well as amiR-Q-1 and -2 (designed for specific targeting of the Q-CMV 3'UTR) transgenic tobacco lines in the tests. T1 progeny derived from three independent primary transformants that expressed high levels of amiRNAs (Fig. 6A) were inoculated with sap extracted from Q-CMV-infected tobacco plants. Chlorosis appeared in upper noninoculated leaves at 6 dpi in all plants of the three amiR-SD-1 lines (lines 4, 5, and 6) and of two amiR-Q-1lines (lines 6 and 10) in 5 of 6 plants of the amiR-Q-1 line 1 and in 14 of 15 wild-type plants (Table 2 and Fig. 6B). A time course ELISA indicated that symptom development positively correlated with Q-CMV CP accumulation (Fig. 6H). High levels of the Q-CMV CP were observed in the amiR-Q-1 and amiR-SD-1 plants infected with Q-CMV, as well as in infected wild-type plants (Fig. 6C). These data suggest that neither amiR-Q-1 nor amiR-SD-1 can confer resistance to Q-CMV infection. In contrast, all of the inoculated plants of all three lines of amiR-Q-2 (lines 1, 2, and 3), amiR-SD-3 (lines 6, 15, and 18), and amiR-SD-2/3/5 (lines 1, 6, and 9) displayed normal appearance and undetectable Q-CMV CP (Fig. 6B and C). Similar results were obtained in a second experiment (Table 2).
|
View this table: [in a new window] |
TABLE 2. Infectivity assay of amiRNA transgenic tobacco challenged with Q-CMV
|
|
View this table: [in a new window] |
TABLE 3. Infectivity assay of amiRNA transgenic tobacco challenged with SD-CMV and Fny-CMV
|
|
|
|---|
Transgenic Arabidopsis plants carrying each of the three amiRNAs—amiR-SD-2, -3, and -5—that target the cleavage hotspots showed resistance to SD-CMV infection. Among the three amiRNAs, amiR-SD-3 seemed to be the best because both amiR-SD-3 transgenic Arabidopsis and tobacco plants had immunity to both subgroup strains of CMV. The amiR-SD-3-programmed RISC cleavage site was detected most frequently in the CMV-infected dcl2/3/4 mutant. Together with the high efficacy of amiR-SD-3-mediated resistance to CMV infection, our results indicate that the amiR-SD-3 target site is a fully accessible RISC target site in the 3'UTR of CMV genome RNAs in natural infection conditions. We cannot clarify how vsiRNAs were produced in the dcl2/3/4 mutant (Fig. 2C). It seems unlikely that the dcl2/3/4 mutant contains the residual activity of DCL2, DCL3, or DCL4 because the triple dcl mutant was generated by standard genetic crosses using the three respective loss-of-function mutations, which are the T-DNA insertional mutations in dcl2-1, dcl3-1, and dcl4-2 (21, 55). DCL1, on the other hand, has been shown to generate 21-nt siRNAs in the triple dcl mutant through hairpin RNA-mediated silencing constructs (16) and to generate 21-nt vsiRNAs in the triple dcl mutant that was infected with DNA viruses (6, 33). We speculate that, in the triple dcl mutant, the TLS region in the 3'UTR might be targeted by DCL1 or a DCL analog and that the resulting siRNAs in turn program the RISC cleavage where cleavage sites were mapped in the CMV-infected dcl2/3/4 mutant (Fig. 2A). In fact, we found that some sequences in the TLS region potentially could form imperfect pairings with the 5'-terminal area of the 3'UTR. On the other hand, a low percentage of resistance to SD-CMV infection in the amiR-SD-4 plants was also correlated with the amiR-SD-4-mediated RISC cleavage site beyond the cleavage hot spot. There were no cleavage sites detected in the dcl2/3/4 mutant within the amiR-SD-4 targeting area, suggesting that the target site is limited to target recognition and cleaved by siRISC, even though it is outside the TLS. The biological function of amiR-SD-4 was confirmed by using GUS-sensor construct via a transient system (data not shown). Therefore, the amiR-SD-4 target area may not be suitable for designing amiRNA to confer CMV resistance, even though the sequence is conserved in the 3'UTRs of all three CMV genomes.
In many plant viruses, sequence divergence is very high, and it may be difficult to select amiRNAs to target sequences that are conserved in most virus isolates. The lack of tools to accurately and reliably predict secondary structures within long RNAs makes it very hard to predict the secondary structures of a viral genome RNA in the natural infection conditions in vivo. Our work provides an experimental approach for analyzing the effects of target site accessibility on engineering effective virus resistance in plants by amiRNAs. By comparing the cleavage sites in the viral RNA of virus-infected wild-type and triple dcl mutant Arabidopsis plants, we can identify siRISC sensitive cleavage sites for the design of valid amiRNAs. The virus resistance levels conferred by amiRNAs that were designed from 5'RACE data suggest that our experimental approach is reliable. We cannot rule out that some mapped cleavage sites obtained from the triple mutant might be from random RNA degradation. However, a result obtained from the triple dcl mutant would reveal sites being cleaved more efficiently and possibly mediated by siRNA-RISC. Our results also suggest that 5'RACE data obtained from transient assays may not truly reflect natural conditions. Therefore, data from natural infections in vivo are required to draw confident conclusions.
We chose the CMV 3'UTR region as a target for amiRNA-mediated antiviral silencing for two reasons. First, the 3'UTR has a less-structured region at the 5' terminus and a stable TLS structure at the 3' terminus, which allowed us to examine whether target site accessibility influenced RISC catalysis in plants. Moreover, we also found that the target recognition was different in the 5'-terminal region. These observations, along with the highly conserved nucleotide sequence in the 3'UTR of all five genomic and subgenomic RNAs, including different subgroup strains of CMV, suggest that the 5'-terminal region of the 3'UTR still contains the conserved structures and/or sequences that are required for biological function. The requirement of conserved structures or sequences for biological function would restrict the viral RNAs from being mutated; therefore, target site selection based on this principle for amiRNA-mediated antiviral silencing may restrict the virus to evading the amiRNA surveillance mechanism and overcoming the specific resistance by mutations. The combination of the high specificity of miRNA cleavage and the high mutability of plant viruses makes it likely that resistance virus variants will emerge, as observed in plants infected with PPV chimeras bearing natural miRNA target sequence (46). We cannot rule out that the immunity of transgenic plants would not last under conditions of large-scale usage and high virus pressure. The polymer amiRNA strategy would be expected to resolve this problem. The polymer strategy is useful to express more than one kind of amiRNAs designed for different target RNAs to confer resistance to viruses, as previously reported by Niu et al. (34).
The second reason for choosing the 3'UTR region as the target is the highly conserved nucleotide sequence in all of the 3'UTR of five genomic and subgenomic RNAs of CMV. Cleavage of multiple CMV genome RNAs simultaneously may result in high resistance to CMV challenge. We obtained 83.3 to 100% resistance to both subgroup strains of CMV in the transgenic Arabidopsis and tobacco plants expressing amiRNAs targeting the 3'UTR region (Tables1, 2, and 3). In the previously reported amiR2b transgenic tobacco plants, ca. 63.6% (including "resistant," "recovery," and "delayed-infection" categories) of plants showed considerable resistance to SD-CMV infection (38). High resistance might be obtained by selection of optimal accessible target sites in the 2b sequence. However, the initially effective knockout of all of the target RNAs would protect the loading of amiRNAs into RISC from competition by vsiRNAs derived from the rapid replication of nontarget RNA1, -3, and -4 and thus maintain the abundance of amiRNA-RISC and target cleavage efficacy.
Plant miRNA-guided silencing has a widespread translational inhibitory component (7), and it might also have an effect on viral RNAs. We cannot rule out the possibility that translation inhibition has also contributed to the virus resistance observed in the plants expressing the 3'UTR-specific amiRNAs.
In conclusion, using an experimental approach with wild-type and RNA interference mutant plants to study the course of RISC target recognition on viral RNA in natural virus infection conditions, we can design 3'UTR-specific amiRNAs that target fully accessible sites to obtain the highest effective resistance to CMV infection on amiRNA transgenic plants. The approach may be limited now to Arabidopsis, a plant of little agronomical interest, and viruses that can infect Arabidopsis. However, rapid developments in plant molecular biology and intensive research findings on RNA silencing in plants, for example, the dcl mutants in rice, are already available (28, 29), thus making it possible for this approach to have a broad application in the future. Moreover, the high conservation of the basic rules in miRNA biology also makes it likely that the information obtained from Arabidopsis will be useful for other plants. As in our case, amiRNAs designed based on the cleavage site analysis in SD-CMV-infected Arabidopsis have a similar effect in transgenic tobacco. We extrapolate that this experimental approach may also be adapted to animal systems in which RNAi mutant cell lines are available such as, for example, the dcr-1 Drosophila mutant (23), in order to apply amiRNAs in therapy.
This research was supported by grants from the Ministry of Science and Technology of China, by the National Basic Research Program 973 (grant 2006CB101900), and by the National Science Foundation of China (grant 30771405 to H.-S.G. and grant 30530500 to R.-X.F.).
Published ahead of print on 3 September 2008. ![]()
Present address: Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»